Jiangsu CoWin Biotech Co., Ltd. (JIANGSU COWIN BIOTECH CO LTD) aksje
688426.SS
JIANGSU COWIN BIOTECH CO LTD
Market Cap
$1,996,763,392
Om Jiangsu CoWin Biotech Co., Ltd. (JIANGSU COWIN BIOTECH CO LTD) aksje
Jiangsu CoWin Biotech Co., Ltd. engages in the research and development, production, and sale of biological products in China. The company provides molecular diagnostic raw material enzymes, nucleic acid collection and protection agents, nucleic acid extraction and purification kits, molecular diagnostic testing reagents, etc. It also offers medical device products, nucleic acid collection and protection, PCR, RT-PCR, and qPCR products, molecular diagnosis, isothermal amplification, nucleic acid mass spectrometry, next generation sequencing, nucleic acid extraction and purification, marker clone transfection, antibody, protein detection products, and scientific research instruments. The company was founded in 2010 and is headquartered in Taizhou, China.
Selskapsinformasjon
225311 Taizhou, China
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.